Peer Review History

Original SubmissionFebruary 15, 2022
Decision Letter - Joohyung Lee, Editor

PONE-D-22-04666

Cognitive and behavioral effects of whole brain conventional or high dose rate (FLASH) proton irradiation in a neonatal Sprague Dawley rat model

PLOS ONE

Dear Dr. Williams,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please address the following issues raised by the reviewers

- Reviewer 1: Provide additional explanation for the limited protective effect of FLASH , which incorporates findings from other groups. The results of the ELISA and Western blot analysis should also be mentioned in the discussion.

- Reviewer 2: Please provide a rationale for the order of the behavioural tasks particularly in regards to the ASR and TSR being close to the start of the testing battery

- Reviewer 3:

1) While the days on which the behavioral tests are described in each section, it would be helpful to have a timeline figure that shows the organization of these days over time. This gives the reader a better idea of the differences in time needed for each behavioral test.

2) The authors should comment on the potential for numerous behavioral tests to interact with or cause changes in future behavioral performance. For example, they noted that the behavioral tests were run from assumed least stressful to most stressful, but it is possible that learning one test could alter learning of subsequent behavioral tests. Given that only one test was repeated and the results were different from the first assessment (5 Gy FLASH), would differences in performances of the other groups potentially be reversed if the rats were re-tested?

3) There were limited effects on the neuronal markers chosen (DRD1, DRD2, DAT, TH, NMDA-NR1). The authors should comment on the lack of measurements typical of other FLASH studies, such as neuroinflammation and neurogenesis and what role these processes might play in the differences between these groups.

==============================

Please submit your revised manuscript by 28th June, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Joohyung Lee, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Funding Section of your manuscript:

“This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following financial disclosure:

“This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation.”

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Competing Interests section:

“These experiments were funded by Varian, a Siemens Healthineers company that granted the authors intellectual freedom to publish the data.”

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: ""This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well designed, careful neurotoxicity investigation of whole brain irradiation using 11 days old rats comparing the neurognitive and behavioral effects and concentration of neurochemical markers after conventional and FLASH proton single dose delivery at two dose levels (5 and 8 Gy).

The authors revealed important findings on the vulnerability of the young rat brain, identified underlying pathomechanism of cognitive and behavioural changes, but found only modes protective effect of the FLASH irradiation, and only at the 5 Gy dose level. They pointed out in the manuscrip correcty the limitations of the experiment, but these limitations are not explaine completely the lack of more pronounced protective effect of the FLASH. The reasons for that and the more evident results of other groups should be discussed in more details. As well as the results of the ELISA and Western blot analysis should be mentioned in the discussion.

If some senteces will be added on these points to the discussion I fully support the publication of this valuable manuscript.

Reviewer #2: Fantastic study and in-depth analysis of many crucial cognitive domains as a part of your behavioural suite, well done. The statistical analysis was also great to show the level of detail, and made all relevant comparisons for not only your hypotheses, but the validity of the measures. One thing that came to mind was the order of the behavioural tasks - I was intrigued to see ASR and TSR so close to the start of the testing battery. My belief was that exposure to the acoustic startle stimuli in the ASR (not sure about TSR) changes the underlying neurobiology of the dopamine system, so that it is different post-exposure to if the animals are naiive to this task. In this way, ASR is typically always measured as the last task? Overall, great quality paper for submission number 1.

Reviewer #3: The current manuscript details an experiment comparing conventionally delivered doses of protons (5 and 8Gy) and the same doses delivered using FLASH dose rates. Overall, the manuscript is well-written and provides a number of behavioral assays covering multiple neurobehavioral domains. I have a few minor comments.

1) While the days on which the behavioral tests are described in each section, it would be helpful to have a timeline figure that shows the organization of these days over time. This gives the reader a better idea of the differences in time needed for each behavioral test.

2) The authors should comment on the potential for numerous behavioral tests to interact with or cause changes in future behavioral performance. For example, they noted that the behavioral tests were run from assumed least stressful to most stressful, but it is possible that learning one test could alter learning of subsequent behavioral tests. Given that only one test was repeated and the results were different from the first assessment (5 Gy FLASH), would differences in performances of the other groups potentially be reversed if the rats were re-tested?

3) There were limited effects on the neuronal markers chosen (DRD1, DRD2, DAT, TH, NMDA-NR1). The authors should comment on the lack of measurements typical of other FLASH studies, such as neuroinflammation and neurogenesis and what role these processes might play in the differences between these groups.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer 1: Provide additional explanation for the limited protective effect of FLASH, which incorporates findings from other groups. The results of the ELISA and Western blot analysis should also be mentioned in the discussion.

Reply. A new paragraph has been added to the Discussion on the protective effects. We argue that the 5-FLASH group produced sparing when there were deficits in the 5-Conv group. We have also incorporated the results of the western and ELISAs.

- Reviewer 2: Please provide a rationale for the order of the behavioural tasks particularly in regards to the ASR and TSR being close to the start of the testing battery

Reply: The following has been added: “A behavioral battery of tests was used to reduce the number of rats used, provide a better characterization of effects for this initial experiment (41), and to be more translatable to human studies that also employ test batteries of different cognitive domains. While test order may have some effect on subsequent behaviors (42), having a day between different tests alleviated many of these issues (43). We also minimized these effects by performing tasks from the least stressful to most stressful (with the exception of the CWM mirror version). While fear potentiated startle can cause changes in dopamine (44), the startle response itself is not known to produce long-term dopamine changes (45).”

- Reviewer 3:

1) While the days on which the behavioral tests are described in each section, it would be helpful to have a timeline figure that shows the organization of these days over time. This gives the reader a better idea of the differences in time needed for each behavioral test.

Reply: A timeline is now provided.

2) The authors should comment on the potential for numerous behavioral tests to interact with or cause changes in future behavioral performance. For example, they noted that the behavioral tests were run from assumed least stressful to most stressful, but it is possible that learning one test could alter learning of subsequent behavioral tests. Given that only one test was repeated and the results were different from the first assessment (5 Gy FLASH), would differences in performances of the other groups potentially be reversed if the rats were re-tested?

Reply: There were 2 different versions of the Cincinnati water maze (CWM) used in this experiment. For the first version, the 5-FLASH group was delayed in learning, as demonstrated by the interaction of exposure x day, but performed equally to the controls by the end of the test. We now make this point better in the Discussion. The mirror version of the CWM while similar requires a completely new set of turns and the 5-FLASH group performed similarly to controls. We have now made this clear that there is consistency in the effects that were observed for the 5-FLASH group.

3) There were limited effects on the neuronal markers chosen (DRD1, DRD2, DAT, TH, NMDA-NR1). The authors should comment on the lack of measurements typical of other FLASH studies, such as neuroinflammation and neurogenesis and what role these processes might play in the differences between these groups.

Reply: We have added the following: A number of studies examining the effect of FLASH in the brain of adult mice have focused on markers of overt neurotoxicity such as glial fibrillary acidic protein staining or bromodeoxyuridine uptake (16-18). However, in this study the approach was to examine the neurotransmitter system related to the functional changes observed in these rats. Therefore the focus was on the dopamine system because of the changes in the CWM and the NMDA receptor subunit 1 (NMDA-NR1) in the hippocampus to confirm the MWM results.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

Reply: style changed as required.

2. Thank you for stating the following in the Funding Section of your manuscript:

“This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Reply: Funding-related text was removed from the manuscript. The Funding Statement should reads as follows:

This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation.

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following financial disclosure:

“This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation.”

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Reply: The financial disclosure should read as follows:

This research was supported by a Research Agreement from Varian, a Siemens Healthineers company. Additional funding support included research support from the TQL Foundation, Cincinnati, OH and Fund the Cure Next Door Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Feedback was provided by Varian for the initial manuscript submission.

4. Thank you for stating the following in the Competing Interests section:

“These experiments were funded by Varian, a Siemens Healthineers company that granted the authors intellectual freedom to publish the data.”

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: ""This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Reply: The Competing Interests statement should read as follows:

These experiments were funded by Varian, a Siemens Healthineers company that granted the authors intellectual freedom to publish the data. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Reply: There are no in text citations to supporting information.

Attachments
Attachment
Submitted filename: PONE-D-22-04666 R1 response to reviewers.docx
Decision Letter - Joohyung Lee, Editor

Cognitive and behavioral effects of whole brain conventional or high dose rate (FLASH) proton irradiation in a neonatal Sprague Dawley rat model

PONE-D-22-04666R1

Dear Dr. Williams,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Joohyung Lee, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: All comments from all reviewers have been addressed well, strengthening the overall quality of the paper. Well done.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Joohyung Lee, Editor

PONE-D-22-04666R1

Cognitive and behavioral effects of whole brain conventional or high dose rate (FLASH) proton irradiation in a neonatal Sprague Dawley rat model

Dear Dr. Williams:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Joohyung Lee

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .